Autism

Investigators are researching the impact of Microbiota Transfer Therapy on Autism and gastrointestinal symptoms in patients with Autism. A phase 1 clinical trial found Autism symptoms reduced nearly 50% two years after microbiota therapy. Read more about the initial trial.

Additional information about the Autism Research Program at Arizona State University is available here.

ASU Researchers Dr. James Adams& Dr. Rosa Krajmalnik-Brown share results from their research.

Hear from patients enrolled in the trial and here.

Dr. James Adams and Dr. Rosa Krajmalnik-Brown share recent updates in Autism research in connection with microbial restoration.

Dr. James Adams shares highlights from his groundbreaking Autism and Pitt Hopkins Disease research at Arizona State University at Achieving Cures Together's fall event, Growing Hope on September 16, 2022.

A Phase 2, double-blind, placebo-controlled study is underway at Arizona State University utilizing Microbiota Transplant Therapy with pediatric and adult patients. More information regarding the current trial is available here.